ABOS - acumenpharm.com Uzoq muddatli majburiyatlarning kapitalga nisbati

Acumen Pharmaceuticals, Inc (ABOS) tovar belgisi

Acumen Pharmaceuticals (ABOS) FDA nazorati ostidagi AQSh markazlari orqali bemorlarni jalb qilgan holda, Altsgeymer kasalligining maqsadli terapiyasi uchun yopiq ekotizimni tashkil etmoqda. Institutlar bilan hamkorlikda kompaniya neyronlarni toksik oqsillardan himoya qilish usullarini ishlab chiqmoqda. Uzoq muddatli qarzdorlikning kapitalga nisbati majburiyatlar muvozanatini aks ettiradi, bunda parametr qiymati 0.18 ga tengdir. Immunoterapiyaning rivojlanishi bemorlarning butun umr davomida davolanishi hisobiga ko'p yillik patent daromadlarini ta'minlaydi.

ABOS - Acumen Pharmaceuticals Inc. Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 28.10.2026 oraligʻida

Acumen Pharmaceuticals (ABOS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Acumen Pharmaceuticals Inc.|ABOS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Acumen Pharmaceuticals, Inc.|ABOS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Acumen Pharmaceuticals|ABOS - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati acumenpharm.com|ABOS - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Acumen Pharmaceuticals|ABOS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati acumenpharm.com|ABOS - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Acumen Pharmaceuticals, Inc.|ABOS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Acumen Pharmaceuticals
Kompaniyaning umumiy tahlili:ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals asosiy tovari

Uzoq muddatli qarzdorlikning kapitalga nisbati moliyaviy leveraj darajasini va balans strukturasining barqarorligini belgilaydi. Ushbu ko'rsatkichning oshishi kredit yukining ortayotganidan dalolat beradi, minimal qiymat esa qarz mablag'laridan yetarlicha foydalanilmayotganini ko'rsatishi mumkin. Uzoq muddatli qarzdorlikning kapitalga nisbatining tarixiy tendentsiyasini tahlil qilish orqali investor bankrotlik xavfini baholaydi. Acumen Pharmaceuticals (ABOS) uchun bu holat Altsgeymer kasalligi dori vositalari sinovlariga bo'lgan yagona mahsulotga bog'liqlik tufayli juda muhimdir. Daromad yo'qligida yuqori qarzdorlik leveraji, agar klinik sinovlar muvaffaqiyatsiz tugasa, inqirozga olib kelishi mumkin.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning kapitalga nisbati BHVN (Biohaven)|Uzoq muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals Inc AMLX|Uzoq muddatli qarzning o'z kapitaliga nisbati TRVI (Trevi Pharma)|Praxis Corp - Uzoq muddatli qarzning kapitalga nisbati|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PRTA|ALEC (Alector) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc. (ANNX)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Omeros Corp. (OMER)|Neurogene Inc. (NGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACIU (acimmune.com)|Voyager Therapeutics, Inc. (VYGR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Neumora NMRA|Uzoq muddatli qarzning kapitalga nisbati Scilex Holding Co. (SCLX)|TVGN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ACOG: Uzoq muddatli qarzning kapitalga nisbati|CGTX (cogrx.com) - Uzoq muddatli qarzning kapitalga nisbati|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com (COYA)|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|CRVO: Uzoq muddatli qarzning kapitalga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati CLNN|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio|Uzoq muddatli kreditlarning kapitalga nisbati gracetx.com (GRCE)|Uzoq muddatli qarzning kapitalga nisbati AIFF|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical KLTO|NRSN: Uzoq muddatli qarzning kapitalga nisbati|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|NEUP (Neuphoria Therapeutics Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com (NERV)|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN - Uzoq muddatli qarzning kapitalga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PTIX|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CRGT: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Cara Therapeutics Inc (CARA)|CHRO: Uzoq muddatli qarzning kapitalga nisbati|ELYM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus MRNS|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO (NeuroBo Pharmaceuticals)|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning kapitalga nisbati|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati